nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.115	0.291	CbGbCtD
Dihydrocodeine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.107	0.271	CbGbCtD
Dihydrocodeine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0491	0.124	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0482	0.122	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.045	0.114	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0307	0.0777	CbGbCtD
Dihydrocodeine—Galantamine—BCHE—peripheral nervous system neoplasm	0.00405	0.609	CrCbGaD
Dihydrocodeine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00295	0.00493	CcSEcCtD
Dihydrocodeine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00295	0.00493	CcSEcCtD
Dihydrocodeine—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.00295	0.00493	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.0029	0.00484	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00287	0.0048	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00287	0.0048	CcSEcCtD
Dihydrocodeine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00287	0.00479	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.00285	0.00477	CcSEcCtD
Dihydrocodeine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00285	0.00475	CcSEcCtD
Dihydrocodeine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00285	0.00475	CcSEcCtD
Dihydrocodeine—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00283	0.00474	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.00283	0.00473	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.00283	0.00473	CcSEcCtD
Dihydrocodeine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00281	0.00469	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.0028	0.00469	CcSEcCtD
Dihydrocodeine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.00274	0.00457	CcSEcCtD
Dihydrocodeine—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00274	0.00457	CcSEcCtD
Dihydrocodeine—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00274	0.00457	CcSEcCtD
Dihydrocodeine—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00273	0.00456	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00271	0.00453	CcSEcCtD
Dihydrocodeine—Hypotension—Melphalan—peripheral nervous system neoplasm	0.0027	0.00451	CcSEcCtD
Dihydrocodeine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.00265	0.00443	CcSEcCtD
Dihydrocodeine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00264	0.00441	CcSEcCtD
Dihydrocodeine—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00263	0.0044	CcSEcCtD
Dihydrocodeine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.00263	0.00439	CcSEcCtD
Dihydrocodeine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.00263	0.00439	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00263	0.00439	CcSEcCtD
Dihydrocodeine—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00261	0.00436	CcSEcCtD
Dihydrocodeine—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00261	0.00436	CcSEcCtD
Dihydrocodeine—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00261	0.00436	CcSEcCtD
Dihydrocodeine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.0026	0.00435	CcSEcCtD
Dihydrocodeine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.0026	0.00435	CcSEcCtD
Dihydrocodeine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.0026	0.00434	CcSEcCtD
Dihydrocodeine—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00258	0.00431	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.00257	0.00429	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00255	0.00426	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00253	0.00423	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00253	0.00423	CcSEcCtD
Dihydrocodeine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00253	0.00422	CcSEcCtD
Dihydrocodeine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.00419	CcSEcCtD
Dihydrocodeine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.0025	0.00419	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.0025	0.00417	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00243	0.00407	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00241	0.00403	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00241	0.00403	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00241	0.00403	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.00241	0.00402	CcSEcCtD
Dihydrocodeine—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.0024	0.00402	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.0024	0.00401	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.0024	0.004	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.0024	0.004	CcSEcCtD
Dihydrocodeine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.00239	0.00399	CcSEcCtD
Dihydrocodeine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00236	0.00394	CcSEcCtD
Dihydrocodeine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00235	0.00393	CcSEcCtD
Dihydrocodeine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00235	0.00392	CcSEcCtD
Dihydrocodeine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00233	0.0039	CcSEcCtD
Dihydrocodeine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00233	0.00389	CcSEcCtD
Dihydrocodeine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00233	0.00389	CcSEcCtD
Dihydrocodeine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00232	0.00387	CcSEcCtD
Dihydrocodeine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00232	0.00387	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.00384	CcSEcCtD
Dihydrocodeine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.0023	0.00384	CcSEcCtD
Dihydrocodeine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00227	0.00379	CcSEcCtD
Dihydrocodeine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00378	CcSEcCtD
Dihydrocodeine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00224	0.00374	CcSEcCtD
Dihydrocodeine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00221	0.0037	CcSEcCtD
Dihydrocodeine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.0022	0.00368	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.0022	0.00367	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00218	0.00364	CcSEcCtD
Dihydrocodeine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00216	0.0036	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00359	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.0021	0.00351	CcSEcCtD
Dihydrocodeine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00209	0.00349	CcSEcCtD
Dihydrocodeine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00347	CcSEcCtD
Dihydrocodeine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00207	0.00346	CcSEcCtD
Dihydrocodeine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00207	0.00346	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00207	0.00346	CcSEcCtD
Dihydrocodeine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00205	0.00342	CcSEcCtD
Dihydrocodeine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00202	0.00338	CcSEcCtD
Dihydrocodeine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00201	0.00336	CcSEcCtD
Dihydrocodeine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.002	0.00335	CcSEcCtD
Dihydrocodeine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.002	0.00335	CcSEcCtD
Dihydrocodeine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.002	0.00334	CcSEcCtD
Dihydrocodeine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00199	0.00333	CcSEcCtD
Dihydrocodeine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00198	0.00331	CcSEcCtD
Dihydrocodeine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00198	0.00331	CcSEcCtD
Dihydrocodeine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00197	0.0033	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00197	0.0033	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00327	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00196	0.00327	CcSEcCtD
Dihydrocodeine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00195	0.00326	CcSEcCtD
Dihydrocodeine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.00195	0.00325	CcSEcCtD
Dihydrocodeine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00194	0.00324	CcSEcCtD
Dihydrocodeine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.00324	CcSEcCtD
Dihydrocodeine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00192	0.00321	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00192	0.0032	CcSEcCtD
Dihydrocodeine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00191	0.00319	CcSEcCtD
Dihydrocodeine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.00317	CcSEcCtD
Dihydrocodeine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00189	0.00316	CcSEcCtD
Dihydrocodeine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00188	0.00314	CcSEcCtD
Dihydrocodeine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00313	CcSEcCtD
Dihydrocodeine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00311	CcSEcCtD
Dihydrocodeine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00311	CcSEcCtD
Dihydrocodeine—Rash—Topotecan—peripheral nervous system neoplasm	0.00186	0.00311	CcSEcCtD
Dihydrocodeine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00186	0.00311	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00185	0.0031	CcSEcCtD
Dihydrocodeine—Headache—Topotecan—peripheral nervous system neoplasm	0.00185	0.00309	CcSEcCtD
Dihydrocodeine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00185	0.00309	CcSEcCtD
Dihydrocodeine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00185	0.00309	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00185	0.00309	CcSEcCtD
Dihydrocodeine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00185	0.00308	CcSEcCtD
Dihydrocodeine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00185	0.00308	CcSEcCtD
Dihydrocodeine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00184	0.00307	CcSEcCtD
Dihydrocodeine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00184	0.00307	CcSEcCtD
Dihydrocodeine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00184	0.00307	CcSEcCtD
Dihydrocodeine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00184	0.00307	CcSEcCtD
Dihydrocodeine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00184	0.00307	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00306	CcSEcCtD
Dihydrocodeine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00183	0.00306	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00183	0.00306	CcSEcCtD
Dihydrocodeine—Rash—Melphalan—peripheral nervous system neoplasm	0.00182	0.00305	CcSEcCtD
Dihydrocodeine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00182	0.00304	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00303	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00301	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.0018	0.003	CcSEcCtD
Dihydrocodeine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00295	CcSEcCtD
Dihydrocodeine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00176	0.00295	CcSEcCtD
Dihydrocodeine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00293	CcSEcCtD
Dihydrocodeine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00175	0.00293	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00175	0.00292	CcSEcCtD
Dihydrocodeine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00175	0.00292	CcSEcCtD
Dihydrocodeine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00174	0.00291	CcSEcCtD
Dihydrocodeine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00174	0.00291	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00289	CcSEcCtD
Dihydrocodeine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00172	0.00287	CcSEcCtD
Dihydrocodeine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.0017	0.00284	CcSEcCtD
Dihydrocodeine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00169	0.00283	CcSEcCtD
Dihydrocodeine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00169	0.00282	CcSEcCtD
Dihydrocodeine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00168	0.00281	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00168	0.0028	CcSEcCtD
Dihydrocodeine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00274	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00163	0.00273	CcSEcCtD
Dihydrocodeine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00162	0.00271	CcSEcCtD
Dihydrocodeine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00262	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00156	0.0026	CcSEcCtD
Dihydrocodeine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00156	0.0026	CcSEcCtD
Dihydrocodeine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00154	0.00258	CcSEcCtD
Dihydrocodeine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00154	0.00257	CcSEcCtD
Dihydrocodeine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00254	CcSEcCtD
Dihydrocodeine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00254	CcSEcCtD
Dihydrocodeine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00151	0.00252	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0015	0.0025	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00148	0.00248	CcSEcCtD
Dihydrocodeine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00245	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00146	0.00245	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00241	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00143	0.00239	CcSEcCtD
Dihydrocodeine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.00238	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00142	0.00237	CcSEcCtD
Dihydrocodeine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00141	0.00236	CcSEcCtD
Dihydrocodeine—Morphine—ABCB1—peripheral nervous system neoplasm	0.00141	0.213	CrCbGaD
Dihydrocodeine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00236	CcSEcCtD
Dihydrocodeine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00234	CcSEcCtD
Dihydrocodeine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00234	CcSEcCtD
Dihydrocodeine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00139	0.00232	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00138	0.0023	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00137	0.00229	CcSEcCtD
Dihydrocodeine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00136	0.00227	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.00135	0.00226	CcSEcCtD
Dihydrocodeine—Rash—Vincristine—peripheral nervous system neoplasm	0.00135	0.00225	CcSEcCtD
Dihydrocodeine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00135	0.00225	CcSEcCtD
Dihydrocodeine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00134	0.00224	CcSEcCtD
Dihydrocodeine—Headache—Vincristine—peripheral nervous system neoplasm	0.00134	0.00224	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00133	0.00223	CcSEcCtD
Dihydrocodeine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.0022	CcSEcCtD
Dihydrocodeine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00216	CcSEcCtD
Dihydrocodeine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00127	0.00212	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00125	0.00209	CcSEcCtD
Dihydrocodeine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00207	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.00124	0.00207	CcSEcCtD
Dihydrocodeine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00206	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00206	CcSEcCtD
Dihydrocodeine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00123	0.00205	CcSEcCtD
Dihydrocodeine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00201	CcSEcCtD
Dihydrocodeine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.0012	0.002	CcSEcCtD
Dihydrocodeine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00199	CcSEcCtD
Dihydrocodeine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00119	0.00199	CcSEcCtD
Dihydrocodeine—Dextromethorphan—ABCB1—peripheral nervous system neoplasm	0.00119	0.179	CrCbGaD
Dihydrocodeine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00119	0.00198	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00192	CcSEcCtD
Dihydrocodeine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00115	0.00191	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00191	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.0019	CcSEcCtD
Dihydrocodeine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00188	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00185	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.0011	0.00184	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—peripheral nervous system neoplasm	0.00109	0.00183	CcSEcCtD
Dihydrocodeine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00109	0.00182	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—peripheral nervous system neoplasm	0.00109	0.00181	CcSEcCtD
Dihydrocodeine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00107	0.00179	CcSEcCtD
Dihydrocodeine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00172	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—peripheral nervous system neoplasm	0.00103	0.00172	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00168	CcSEcCtD
Dihydrocodeine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000991	0.00166	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000989	0.00165	CcSEcCtD
Dihydrocodeine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000979	0.00164	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000954	0.00159	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000953	0.00159	CcSEcCtD
Dihydrocodeine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000943	0.00158	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000939	0.00157	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000931	0.00156	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000917	0.00153	CcSEcCtD
Dihydrocodeine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000908	0.00152	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000906	0.00151	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000881	0.00147	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000873	0.00146	CcSEcCtD
Dihydrocodeine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000872	0.00146	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000869	0.00145	CcSEcCtD
Dihydrocodeine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000866	0.00145	CcSEcCtD
Dihydrocodeine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000864	0.00144	CcSEcCtD
Dihydrocodeine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00084	0.0014	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000839	0.0014	CcSEcCtD
Dihydrocodeine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000831	0.00139	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000807	0.00135	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000801	0.00134	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.0008	0.00134	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.00133	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000794	0.00133	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000776	0.0013	CcSEcCtD
Dihydrocodeine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000772	0.00129	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000769	0.00128	CcSEcCtD
Dihydrocodeine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000768	0.00128	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000741	0.00124	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000735	0.00123	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000714	0.00119	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00119	CcSEcCtD
Dihydrocodeine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000687	0.00115	CcSEcCtD
Dihydrocodeine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000665	0.00111	CcSEcCtD
Dihydrocodeine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000642	0.00107	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000636	0.00106	CcSEcCtD
Dihydrocodeine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000618	0.00103	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.00103	CcSEcCtD
Dihydrocodeine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000612	0.00102	CcSEcCtD
Dihydrocodeine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000612	0.00102	CcSEcCtD
Dihydrocodeine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000609	0.00102	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000993	CcSEcCtD
Dihydrocodeine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000964	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000571	0.000955	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000567	0.000947	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000566	0.000946	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000941	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000892	CcSEcCtD
